INOVIO to Participate in the H.C. Wainwright 27th Annual Global Investment Conference
INOVIO (NASDAQ:INO), a biotechnology company specializing in DNA medicines for HPV-associated diseases, cancer, and infectious diseases, will participate in the H.C. Wainwright 27th Annual Global Investment Conference.
The company will provide a pre-recorded presentation available on demand starting September 5, 2025, at 7:00 AM ET. INOVIO's management team will conduct in-person one-on-one meetings with investors during the conference. The webcast will remain accessible for 90 days through the provided link and INOVIO's Investor Relations Events page.
INOVIO (NASDAQ:INO), azienda biotecnologica specializzata in terapie a base di DNA per malattie associate a HPV, tumori e malattie infettive, parteciper脿 alla H.C. Wainwright 27th Annual Global Investment Conference.
L'azienda render脿 disponibile una presentazione preregistrata on demand a partire dal 5 settembre 2025 alle 7:00 AM ET. Il team dirigenziale di INOVIO terr脿 incontri individuali in presenza con gli investitori durante la conferenza. Il webcast sar脿 accessibile per 90 giorni tramite il link fornito e la pagina Eventi Investor Relations di INOVIO.
INOVIO (NASDAQ:INO), compa帽铆a biotecnol贸gica especializada en medicamentos de ADN para enfermedades asociadas al VPH, c谩ncer y enfermedades infecciosas, participar谩 en la H.C. Wainwright 27th Annual Global Investment Conference.
La empresa ofrecer谩 una presentaci贸n grabada disponible on demand a partir del 5 de septiembre de 2025 a las 7:00 AM ET. El equipo directivo de INOVIO mantendr谩 reuniones individuales presenciales con inversores durante la conferencia. El webcast permanecer谩 accesible durante 90 d铆as a trav茅s del enlace facilitado y de la p谩gina de Eventos de Relaciones con Inversores de INOVIO.
INOVIO (NASDAQ:INO))電� HPV 甏�霠� 歆堩櫂, 鞎� 氚� 鞝勳椉氤戩潉 鞙勴暅 DNA 鞚橃暯頀堨潉 鞝勲鞙茧 頃橂姅 靸濍獏瓿淀暀 旮办梾鞙茧, H.C. Wainwright 27th Annual Global Investment Conference鞐� 彀戈皜頃╇媹雼�.
须岇偓电� 2025雲� 9鞗� 5鞚� 鞓れ爠 7:00(氙戈淡 霃欕秬 鞁滉皠)攵�韯� 欤茧順曥溂搿� 鞁滌箔 臧�電ロ暅 靷爠 雲鬼檾 氚滍憸 鞓侅儊鞚� 鞝滉车頃╇媹雼�. INOVIO 瓴届榿歆勳潃 旎嵓霟办姢 旮瓣皠 霃欖晥 韴瀽鞛愲摛瓿� 雽�氅� 1:1 氙疙寘鞚� 歆勴枆頃� 鞓堨爼鞛呺媹雼�. 鞗轨簮鞀ろ姼電� 鞝滉车霅� 毵來伂鞕� INOVIO 韴瀽鞛� 甏�瓿� 鞚措菠韸� 韼橃澊歆�毳� 韱淀暣 90鞚�臧� 瓿勳啀 鞚挫毄頃� 靾� 鞛堨姷雼堧嫟.
INOVIO (NASDAQ:INO), soci茅t茅 de biotechnologie sp茅cialis茅e dans les m茅dicaments 脿 base d'ADN pour les maladies li茅es au HPV, le cancer et les maladies infectieuses, participera 脿 la H.C. Wainwright 27th Annual Global Investment Conference.
La soci茅t茅 proposera une pr茅sentation pr茅enregistr茅e disponible 脿 la demande 脿 partir du 5 septembre 2025 脿 7:00 AM ET. L'茅quipe de direction d'INOVIO tiendra des r茅unions individuelles en personne avec des investisseurs pendant la conf茅rence. Le webcast restera accessible pendant 90 jours via le lien fourni et la page 脡v茅nements des Relations Investisseurs d'INOVIO.
INOVIO (NASDAQ:INO), ein Biotechnologieunternehmen, das sich auf DNA-Medikamente f眉r HPV-assoziierte Erkrankungen, Krebs und Infektionskrankheiten spezialisiert hat, wird an der H.C. Wainwright 27th Annual Global Investment Conference teilnehmen.
Das Unternehmen stellt ab dem 5. September 2025 um 7:00 AM ET eine vorab aufgezeichnete Pr盲sentation On-Demand zur Verf眉gung. Das Management von INOVIO wird w盲hrend der Konferenz pers枚nliche Einzelgespr盲che mit Investoren f眉hren. Der Webcast bleibt f眉r 90 Tage 眉ber den bereitgestellten Link und die Investor-Relations-Eventseite von INOVIO zug盲nglich.
- None.
- None.
H.C. Wainwright 27th Annual Global Investment Conference
Presentation available: Beginning Friday, September 5, 2025, 7:00AM ET
Format: Pre-recorded webcast
Link:
The webcast will be available for 90 days at the link above or on the INOVIO Investor Relations Events page: .听
About INOVIO
INOVIO is a biotechnology company focused on developing and commercializing DNA medicines to help treat and protect people from HPV-related diseases, cancer, and infectious diseases. INOVIO's technology optimizes the design and delivery of innovative DNA medicines that teach the body to manufacture its own disease-fighting tools. For more information, visit .听
Contacts
Media: Jennie Willson, (267) 429-8567, [email protected]
Investors: Peter Vozzo, ICR Healthcare, 443-213-0505,聽[email protected]
View original content to download multimedia:
SOURCE INOVIO Pharmaceuticals, Inc.
FAQ
When is INOVIO's presentation at the H.C. Wainwright Conference 2025?
How long will INOVIO's H.C. Wainwright Conference presentation be available?
What type of meetings will INOVIO conduct at the H.C. Wainwright Conference?
Where can investors access INOVIO's H.C. Wainwright Conference presentation?
